NIH-funded research R01 grant

Investigating how synaptic vesicles transport neurotransmitters in the brain

Official title: Structural and functional investigations on synaptic vesicular transporters

Funded at St. Jude Children's Research Hospital · NIH-11045719 · Data updated 2026-11-12

This study is looking at how a protein called SV2 helps brain cells communicate and how it might be affected by epilepsy and antiepileptic drugs, with the goal of finding better treatments for neurological conditions.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionSt. Jude Children's Research Hospital
NIH-funded
Lab location1 site (Memphis, United States)
Project startMarch 1, 2024
Project endFebruary 28, 2029
Funding year2025
Award (this year)$471,050
NIH project number5R01NS133147-02
Project IDNIH-11045719 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with epilepsy or other neurological disorders linked to synaptic transporter dysfunction.

Less likely to help

Patients with neurological conditions unrelated to synaptic vesicle transporters may not benefit from this research.

What this research studies

This research focuses on understanding the role of synaptic vesicles in neurotransmitter release, which is crucial for communication between neurons in the brain. It aims to explore the function of a specific protein, SV2, that is involved in this process and is linked to conditions like epilepsy. Using advanced techniques such as cryo-electron microscopy and mass spectrometry, the research will investigate how SV2 operates and how antiepileptic drugs affect its function. This could lead to a better understanding of how to treat neurological diseases associated with transporter defects.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for epilepsy and other neurological disorders by enhancing our understanding of synaptic function.

How similar studies have gone: Previous research has shown promise in understanding synaptic transporters, but this specific investigation into SV2 is relatively novel.

Where this research is happening

  • St. Jude Children's Research Hospital
    Memphis, United States
    Active

Researchers

  • Principal investigator: Lee, Chia-Hsueh — St. Jude Children's Research Hospital
  • Study coordinator: Lee, Chia-Hsueh

Related research

Other NIH-funded projects on the same topics.

  • Investigating frailty and aging in childhood cancer survivors

    This study is looking at childhood cancer survivors to see how they might face health challenges similar to older adults as they grow up, and it aims to find ways to help them stay strong and healthy by exploring treatments that could improve their well-being.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-9890475

  • Investigating a specific type of leukemia in children caused by genetic changes.

    This study is looking at how certain proteins linked to leukemia affect kids and teens with high-risk blood cancers, and the researchers hope to find new ways to treat these conditions by learning more about how the disease works.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-9834651

  • Accessible, label-free optical imaging to reveal disease signals

    A brain-friendly, patient-centered imaging approach aims to uncover hidden disease signals in cells and tissues without labels or dyes.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11627327

  • Targeting the SCP4 pathway in acute myeloid leukemia (AML)

    Aims to uncover how the SCP4 signaling pathway drives AML and how it could be blocked to help patients.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11617813

  • Blocking cancer-causing cMYC tricks after pregnancy changes in the breast

    Researchers are testing how pregnancy and aging reshape the breast before cancer risk, using patient-reinformed models to see if it changes how dangerous cMYC signals behave.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11615605

  • Targeting aberrant enhancer landscapes in pancreatic cancer

    A patient-facing look at a project that aims to understand how pancreatic cancer changes its cell identity and what that means for treatment.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11611138

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.